IRIS
FLAMMINI, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.912
EU - Europa 1.902
AS - Asia 838
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 1
Totale 4.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.887
CN - Cina 569
FI - Finlandia 392
IT - Italia 386
IE - Irlanda 380
SE - Svezia 349
DE - Germania 139
SG - Singapore 128
UA - Ucraina 110
TR - Turchia 78
IN - India 42
CI - Costa d'Avorio 38
NL - Olanda 35
CA - Canada 25
BE - Belgio 24
GB - Regno Unito 21
FR - Francia 17
CZ - Repubblica Ceca 15
PL - Polonia 6
RO - Romania 6
AT - Austria 5
CH - Svizzera 5
EU - Europa 5
JP - Giappone 4
KR - Corea 4
VN - Vietnam 4
RU - Federazione Russa 3
ES - Italia 2
IR - Iran 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SC - Seychelles 2
CM - Camerun 1
DZ - Algeria 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
LU - Lussemburgo 1
MC - Monaco 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.703
Salva come PNG Salva come JPEG
Città #
Chandler 398
Dublin 379
Ann Arbor 222
Parma 161
Dearborn 149
Jacksonville 144
Beijing 125
Ashburn 117
Boardman 99
Singapore 84
Shanghai 80
Nanjing 76
Izmir 73
Princeton 60
New York 52
Wilmington 39
Abidjan 38
Bremen 35
Groningen 33
San Mateo 29
Bangalore 27
Kunming 25
Chicago 24
Helsinki 24
Milan 24
Brussels 23
Des Moines 23
Hebei 22
Jinan 22
Shenyang 20
Guangzhou 19
Nanchang 19
Toronto 18
Changsha 17
Fremont 16
Hefei 16
Seattle 16
Los Angeles 15
Norwalk 13
Redmond 13
Brno 12
Jiaxing 12
Houston 11
Tianjin 11
Munich 10
Montegaldella 9
Santa Clara 9
Grafing 8
Modena 8
Woodbridge 8
Dallas 7
Redwood City 7
Reggio Emilia 7
Hangzhou 6
Pune 6
Zhengzhou 6
Bologna 5
Kraków 5
Taizhou 5
West Jordan 5
Altidona 4
Ardea 4
Carpi 4
Düsseldorf 4
Falls Church 4
Haikou 4
Kocaeli 4
Lanzhou 4
Palermo 4
Pesaro 4
Rome 4
Baotou 3
Brescia 3
Chengdu 3
Finale Emilia 3
Fuzhou 3
Mantova 3
Mestre 3
Ningbo 3
Ottawa 3
Stockholm 3
Timisoara 3
Tulsa 3
Vienna 3
Zurich 3
Assago 2
Bergamo 2
Brooklyn 2
Chiari 2
Collecchio 2
Dong Ket 2
Duncan 2
Fairfield 2
Florence 2
Genzano di Lucania 2
Gioia Tauro 2
Gualtieri 2
Hanoi 2
Hyderabad 2
Incheon 2
Totale 3.062
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 181
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 157
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 138
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 123
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 108
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 108
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 107
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 102
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 98
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 97
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 97
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 94
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 91
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 91
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 90
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 83
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 83
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 82
Hake fish bone as a calcium source for efficient bone mineralization 82
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 82
Analgesic activity of new hybrid muscarinic agonists in mice 81
Antitumoral effect of a nanotechnology-based photodynamic therapy. 81
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 79
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 78
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 78
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 77
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 76
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 76
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 75
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 74
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 72
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 72
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 70
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 69
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 68
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 66
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 65
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 65
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 64
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 64
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 63
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 63
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 63
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 62
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 60
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 59
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 59
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 59
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 58
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 56
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 54
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 53
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 52
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 52
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 50
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 50
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 50
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 48
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 44
New selective PDE4D inhibitors devoid of sedative effects in mice 41
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 41
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 40
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 30
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 24
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 22
Totale 4.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020611 0 0 41 17 58 127 119 21 63 94 28 43
2020/2021444 7 43 22 23 73 37 56 19 68 21 56 19
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/2025273 84 87 102 0 0 0 0 0 0 0 0 0
Totale 4.797